Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001842952-25-000030
Filing Date
2025-03-20
Accepted
2025-03-20 16:44:17
Documents
6
Effectiveness Date
2025-03-20
Reference 429
333-278127

Document Format Files

Seq Description Document Type Size
1 S-8 cntxs-82025.htm S-8 69609
2 EX-FILING FEES cntx-formsx82025evergreenx.htm EX-FILING FEES 21578
3 EX-5.1 cntx-ex51opinionforformsx8.htm EX-5.1 14128
4 EX-23.1 cntx-ex231cohnreznickconse.htm EX-23.1 2377
5 image_0.jpg GRAPHIC 90
6 picture1.jpg GRAPHIC 6731
  Complete submission text file 0001842952-25-000030.txt   118612
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285967 | Film No.: 25757105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)